Track market-moving stories before they get noisy

The First Publicly Listed Fusion Stock Just Started Trading, and It Did Not Arrive Quietly PR Newswire VANCOUVER

The medical supply industry has entered the second half of 2026 from a position of strength, supported by resilient healthcare utilization, rising specialty care demand, increasing adoption of digital technologies and continued migration of patient care toward lower-cost outpatient settings.

Across major industry participants, management highlighted healthy procedure volumes, growing investment by healthcare providers, expanding specialty pharmaceutical utilization and stronger demand for technology-enabled workflow solutions. At the same time, companies continue to modernize supply chains through automation and AI while investing in value-added services that improve efficiency for providers and patients. However, the industry is not without challenges. Tariff-related cost pressures, pricing changes tied to healthcare policy, uneven demand in certain product categories and macroeconomic uncertainty continue to create operational complexity.

Companies with diversified business models, technology leadership, specialty exposure and disciplined capital allocation appear well positioned to capitalize on these favorable industry tailwinds through the remainder of 2026. Per a Markets and Markets report, the global medical supplies industry is expected to reach $163.5 billion by 2027, at a CAGR of 3.4% in the 2022-2027 period. Industry participants, such as McKesson (MCK - Free Report) , Cardinal Health (CAH - Free Report) , West Pharmaceutical Services (WST - Free Report) , Align Technology (ALGN - Free Report) and Henry Schein (HSIC - Free Report) , are likely to ride on the favorable macro trends amid lingering tariff risks.

Industry Description The global dental industry consists of companies that design, develop, make and market dental products, such as consumables, laboratory products and specialty items. Some of these companies also offer software and systems for practice management, patient education and office administration. Dental stocks have been drawing attention amid a recovery in sales following the weakness caused by pandemic-induced disruptions. The market has been recovering and maintaining its position.

Dental care is provided based on the advice and recommendations of the American Dental Association and the Centers for Disease Control and Prevention. Thanks to the rebound seen among companies in this space, patient volumes have been increasing steadily following the removal of COVID-19 restrictions.

Major Trends Shaping the Future of the Medical Dental Supplies Industry Specialty Care and Outpatient Healthcare Support Industry Growth: Healthcare delivery continues shifting toward specialty therapies, community-based care and non-acute treatment settings, creating sustained demand for medical distribution and support services. Specialty pharmaceuticals, oncology services, home-based care, ambulatory surgical centers and precision medicine remain among the industry's fastest-growing segments.

Companies are expanding provider networks, investing in specialty capabilities and strengthening patient access platforms to benefit from higher-acuity care migrating outside traditional hospitals. This structural transition supports long-term volume growth while increasing demand for integrated distribution, logistics and patient support solutions.

AI, Automation and Digital Innovations: Medical supply companies are increasingly leveraging AI, automation and cloud-based platforms to improve provider productivity, optimize supply chains and enhance patient engagement. Investments range from AI-enabled inventory planning and automated distribution centers to digital treatment planning, practice management software and workflow automation.

These technologies are helping providers improve efficiency, reduce administrative burdens and expand patient access while allowing distributors to enhance operational resilience and margins. As healthcare systems prioritize productivity improvements, technology-enabled service offerings are becoming an increasingly important source of competitive advantage and long-term growth.

Increasing Burden of Oral Diseases and an Aging Population: The U.S. dental equipment market is structurally supported by demographic aging and rising disease prevalence. Older cohorts account for a disproportionate share of restorative and surgical procedures, reflecting a higher incidence of caries, periodontal disease, and tooth loss. With the 65+ population expanding, demand visibility remains strong, reinforcing procedure volumes and equipment utilization across practices.

Growing Awareness and Emphasis on Preventive Care: Rising awareness of oral hygiene and preventive care is shifting demand toward early-stage interventions. Increased utilization of fluoride treatments, sealants, and prophylaxis products reflects a broader transition toward prevention-focused dentistry, supporting recurring revenue streams within consumables.

Minimally Invasive and Cosmetic Dentistry Trends: Patient preference is increasingly skewed toward minimally invasive and aesthetic procedures, including whitening and veneers. This trend is expanding demand for specialized materials and precision equipment, while also increasing procedure frequency and average spend per patient.

Expansion of Dental Clinics and Group Practices: The ongoing expansion of dental clinics, DSOs, and hospital-based practices is structurally increasing equipment demand. Higher patient throughput, standardized treatment protocols, and procurement efficiencies are driving consistent product utilization across growing care networks.

Regional Market Growth Drivers: Emerging markets, particularly in Asia-Pacific, are exhibiting above-average growth due to rising healthcare expenditure, improving access, and supportive policy frameworks. Dental tourism and expanding middle-class demand are further accelerating equipment adoption in these regions

Policy Changes and Ongoing Cost Inflation: Despite healthy demand, companies continue navigating an increasingly complex operating environment. Tariffs, healthcare policy changes, pharmaceutical pricing reforms under the Inflation Reduction Act, higher freight costs and inflationary pressures remain important headwinds.

Several companies also cited softer demand in select product categories, such as respiratory diagnostics following a mild flu season, while competitive pricing in certain technology markets continued to weigh on margins. Although management remains confident in mitigating these pressures through pricing actions, productivity initiatives and supply-chain improvements, these headwinds are likely to remain through the second half of 2026.

Zacks Industry Rank The Zacks Medical Dental Supplies industry falls within the broader Zacks Medical sector.

It carries a Zacks Industry Rank #68, which places it in the top 28% of 243 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all member stocks, indicates dull near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Before we present a few dental supply stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry Performance The industry has outperformed its sector but underperformed the S&P 500 composite in the past year.

Stocks in this industry collectively gained 10.2% compared with the Zacks Medical sector’s rise of 9.6%. The S&P 500 has surged 24.2% in the same time frame.

One-Year Price Performance

Industry's Current Valuation On the basis of the forward 12-month price-to-earnings (P/E), which is commonly used for valuing medical stocks, the industry is currently trading at 16.83X compared with the S&P 500’s 21.23X and the sector’s 21.07X.

Over the past five years, the industry has traded as high as 21.75X and as low as 15.53X, with the median being 18.44X, as the charts show.

Price-to-Earnings Forward Twelve Months (F12M)

Price-to-Earnings Forward Twelve Months (F12M)

5 Key Dental Supply Picks McKessonremains one of the strongest beneficiaries of the industry's accelerating shift toward specialty care and technology-enabled healthcare services. The company continues to expand its oncology and multispecialty ecosystem through the integration of Core Ventures and PRISM Vision, broadening its presence across community oncology, retina and ophthalmology.

Management also highlighted continued momentum in biopharma services, where rising demand for access and affordability programs, particularly for complex specialty therapies, is strengthening its value proposition. AI-enabled workflow tools, automation and advanced distribution capabilities are further improving physician productivity, patient access and supply-chain efficiency. Investments in AI-powered inventory planning, highly automated distribution centers and technology infrastructure are expected to support operating leverage while enhancing service reliability.

McKesson's disciplined capital allocation, robust free cash flow generation and continued investment in automation reinforce confidence in sustained earnings growth. However, the company continues to operate in a dynamic policy environment, with pharmaceutical pricing reforms, evolving utilization patterns and continued investments in technology infrastructure likely to influence near-term profitability.

The Zacks Consensus Estimate for fiscal 2027 revenues indicates an improvement of 7.3% from the year-ago reported figure, while the same for earnings implies a rise of 13.2%. MCK carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Price and Consensus: MCK

Cardinal Healthhas entered the second half of 2026 with strong momentum, driven by broad-based pharmaceutical demand and rapid expansion across its higher-growth businesses. Specialty pharmaceuticals remain the primary growth engine, with specialty revenues expected to exceed $50 billion during fiscal 2026, supported by robust demand for oncology therapies, GLP-1 products and branded medicines.

Beyond pharmaceutical distribution, the company continues to benefit from accelerating growth in At-Home Solutions, Nuclear and Precision Health Solutions and OptiFreight Logistics, reflecting increasing demand for decentralized care, theranostics and healthcare supply-chain optimization. Strategic acquisitions, including Advanced Diabetes Supply, are expanding Cardinal Health's chronic care capabilities while strengthening its long-term growth platform.

Operational discipline and resilient execution have also enabled the company to navigate complex market conditions effectively. Nevertheless, tariff-related costs remain a significant headwind for the Global Medical Products and Distribution segment, while the Navista goodwill impairment underscores execution risks within certain growth initiatives. Future performance will also depend on continued success in managing supply-chain costs and evolving healthcare policy changes.

The Zacks Consensus Estimate for fiscal 2026 revenues indicates an improvement of 15.1% from the year-ago reported figure, while the same for earnings implies a rise of 30.7%. CAH carries a Zacks Rank #2 at present.

Price and Consensus: CAH

West PharmaceuticalServices remainswell positioned to benefit from long-term growth in biologics and high-value injectable therapies, supported by sustained demand for advanced drug containment and delivery solutions. Management emphasized continued strength across its High-Value Products portfolio, with increasing customer adoption of premium components and proprietary delivery technologies driving favorable product mix and margin expansion.

The company's strategy is also supported by healthy demand for biologics, expanding capacity investments and growing participation in next-generation injectable medicines. This positions West Pharma to capitalize on structural trends in pharmaceutical innovation. Operational improvements and disciplined manufacturing execution continue to strengthen profitability while reinforcing customer relationships with leading biopharma companies.

However, management acknowledged that macroeconomic uncertainty, customer inventory normalization in selected product categories and the pace of new drug commercialization could create periodic revenue variability. Despite these risks, West Pharma's innovation-led portfolio, diversified customer base and focus on high-value solutions provide a solid foundation for continued growth through the remainder of 2026.

The Zacks Consensus Estimate for 2026 revenues indicates an improvement of 8.4% from the year-ago reported figure, while the same for earnings implies a rise of 18%. WST carries a Zacks Rank of 2 at present.

Price and Consensus: WST

Align Technologyis well positioned to benefit from the continued digitization of orthodontics and the growing adoption of clear aligner therapy. The company delivered record Invisalign case shipments in the first quarter, supported by broad-based growth across adults, teens and younger patients, while international markets continued to outpace North America. Management also highlighted strong momentum in dental service organizations (DSOs), which are increasingly adopting Align Technology's integrated digital platform to improve clinical workflows and patient conversion.

The expanding installed base of iTero scanners, rising adoption of exocad software and the rollout of restorative treatment solutions further strengthen Align Technology's digital ecosystem and create opportunities beyond orthodontics. Financing programs, doctor subscription models and treatment planning services are also improving affordability, clinician confidence and utilization, supporting long-term case growth. However, softer patient traffic in parts of the U.S. retail channel, pricing pressure from lower-cost scanner offerings and uneven macroeconomic conditions across certain markets remain key challenges to monitor through the remainder of 2026.

The Zacks Consensus Estimate for 2026 revenues indicates an improvement of 3.7% from the year-ago reported figure, while the same for earnings implies a rise of 8.1%. ALGN carries a Zacks Rank #2 at present.

Price and Consensus: ALGN

Henry Scheinhas entered the second half of 2026 with improving operating momentum, supported by market share gains, expanding digital capabilities and a sharpened focus on operational excellence. Management sees healthy demand across dental markets, with continued investments by dental service organizations (DSOs) and practitioners supporting equipment, merchandise and specialty product sales.

The company's integrated portfolio — including distribution, specialty products, practice management software and value-added services — positions it to benefit from customers' increasing focus on productivity and workflow optimization. AI-enabled practice management solutions, cloud-based software adoption and ongoing value creation initiatives are expected to drive margin expansion while strengthening customer engagement. Growth in value implants, home solutions and non-acute care channels provides additional tailwinds, while restructuring initiatives and supply-chain efficiencies should further enhance profitability.

Nevertheless, Henry Schein continues to face pricing pressure in digital equipment from new market entrants, softer demand for respiratory diagnostic products following a mild flu season, and cost inflation from higher freight and merchandise prices. Effective execution of its transformation initiatives will remain critical to sustaining earnings growth through the rest of 2026.

The Zacks Consensus Estimate for 2026 revenues indicates an improvement of 4.1% from the year-ago reported figure, while the same for earnings implies a rise of 7%. HSIC carries a Zacks Rank of 2 at present.

Price and Consensus: HSIC

HomeDividends AnalysisDividend Strategy

SummaryThe Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns.I prioritize a diversified mix of ETFs and individual stocks across sectors, balancing dividend income, growth, and capital appreciation while mitigating downside risk.Key metrics include a 3.75% weighted average dividend yield, low payout ratios, and low beta factors, supporting long-term portfolio resilience.Financials, Consumer Staples, and Healthcare sectors dominate the allocation, reflecting a focus on stability and superior risk-reward profiles. MoMo Productions/DigitalVision via Getty Images

Investment Thesis The current market environment is characterized by high geopolitical uncertainty, relatively high valuations of companies in relation to their growth profile and overall risk-reward profile, and a relatively high inflation rate.

The

11.58K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SCHD, O, PM, RY, AAPL, T, MA, MAIN, JNJ, BAC, ARCC, TCPC, BTI, BHP, MSFT, NKE, XOM, HDV, VICI, BLK, RQI, PFE, MO, SCHO, PEP, GOOG, JPM, V, KO, BRK.B, LIN, BEP, BBSEY, AMZN, PYPL, PBR, RIO, NEE, CNQ, ARE, UL, NVO, NVS, ALIZF, LVMHF, META, DHLGY, CVX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Key Takeaways Aehr expects fiscal 2026 revenues at the high end of its $45-$50 million guidance range.AEHR sees Q4 profitability supported by bookings, higher shipments and better factory utilization.Aehr's softer WaferPak demand may pressure revenue growth and gross margin despite system gains. Aehr Test Systems (AEHR - Free Report) is scheduled to report its fourth-quarter fiscal 2026 earnings on July 14.

In the third quarter of fiscal 2026, Aehr reported a loss of 5 cents per share that beat the Zacks Consensus Estimate by 37.5%. However, revenues of $10 million lagged the consensus mark by 20.05%.

The Zacks Consensus Estimate for fiscal fourth-quarter loss is pegged at a penny, unchanged over the past 30 days, and flat from the figure reported in the year-ago quarter. The consensus mark for fiscal first-quarter sales is pegged at $18.7 million, suggesting 32.7% growth from the figure reported in the year-ago quarter.

Let’s see how things have shaped up for the upcoming announcement.

Key Factors to Consider for AEHR’s Q4 EarningsAehr’s fiscal fourth-quarter results are expected to have benefited from strong backlog and booking conversion. Fiscal third-quarter bookings exceeded $37 million, and Aehr added another $12.2 million of bookings in the first five weeks of the fourth quarter. Management expects fiscal 2026 revenues to finish at the high end of the $45-$50 million guidance range and return to profitability in the fourth quarter of fiscal 2026.

Aehr’s fiscal fourth-quarter results are expected to have benefited from the new silicon photonics customer that ordered multiple FOX-XP wafer-level burn-in systems, engineering and production systems, WaferPak contactors and automated aligners. These systems were scheduled to be shipped in the to-be-reported quarter. The company’s results are also expected to have benefited from strong demand from AI customers.

Aehr expects gross margin to improve in the fiscal fourth quarter, driven by higher shipment volumes, better factory utilization and improved absorption of fixed manufacturing costs.

However, Aehr’s high-margin consumables business remained under pressure. The company noted that several customers had purchased systems ahead of demand and were only gradually utilizing existing capacity, reducing near-term WaferPak orders. Since WaferPaks carry higher margins than systems, the softer consumables mix likely weighed on both fourth-quarter revenue growth and gross margin, even as system shipments improved

What Our Model SaysAccording to the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here.

Aehr currently has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Stocks to ConsiderHere are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases:

Alphabet (GOOGL - Free Report) has an Earnings ESP of +1.30% and a Zacks Rank #2 at present. Alphabet is set to report second-quarter 2026 results on July 22. You can see the complete list of today’s Zacks #1 Rank stocks here.

Amphenol (APH - Free Report) has an Earnings ESP of +0.43% and a Zacks Rank #2 at present. Amphenol is slated to report second-quarter 2026 results on July 29.

Lam Research (LRCX - Free Report) has an Earnings ESP of +1.13% and a Zacks Rank #2 at present. Lam Research is scheduled to report fourth-quarter fiscal 2026 results on July 29.

Key Takeaways Central Garden's cost and simplicity program is strengthening efficiency and business resilience.CENT expanded gross and operating margins through sales leverage, cost management and simplification.CENT is optimizing manufacturing and distribution to improve flexibility and support profitable growth. Central Garden & Pet Company (CENT - Free Report) noted that its Cost and Simplicity program has fundamentally strengthened the business. The company believes that these efforts have improved operational efficiency, enhanced organizational resilience and created a better-run business. Management also emphasized that this focus on cost discipline and simplification is now embedded in the company’s operating model and continues to shape the way it manages and executes its business.

The company expanded second-quarter fiscal 2026 gross margin by 30 basis points to 33.1%, while operating margin improved to 12.6% from 11.2% in the prior-year period. Higher sales leverage, prudent cost management and ongoing organizational simplification supported margin expansion while allowing continued investment in key growth initiatives. Management highlighted multiple initiatives to simplify the business while enhancing execution and operational efficiency. As part of these efforts, the company relocated its DoMyOwn business to its Covington fulfillment center to improve delivery speed, reduce costs and increase network flexibility.

Additionally, in the last earnings call transcript the company noted that it is consolidating Top Dog Best Bully Sticks manufacturing into its dog and cat platform in New Jersey to leverage scale and manufacturing capabilities better. The company also entered into a joint venture with Phillips Pet Food & Supplies while retaining a 20% ownership stake. Management believes that the partnership will strengthen and enhance the agility of its nationwide distribution network, simplify operations and allow the company to focus more directly on expanding its Central branded portfolio.

The company believes that the streamlined structure supports better execution, stronger productivity and improved cost control while creating room to continue investing behind brands and innovation. Management also reaffirmed fiscal 2026 earnings guidance, noting that ongoing margin discipline and portfolio optimization remain central to its operating strategy despite inflation, tariffs and a promotional retail environment. Management expects adjusted earnings to be $2.70 per share or better.

The Zacks Rundown for CENTShares of this Zacks Rank #3 (Hold) company have soared 29.6% in the past six months compared with the industry’s growth of 12.4%.

Image Source: Zacks Investment Research

From a valuation standpoint, CENT trades at a forward price-to-earnings ratio of 14.04, lower than the industry’s average of 14.76.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for CENT’s current and next fiscal year earnings implies year-over-year growth of 5.9% and 7.3%, respectively.

Image Source: Zacks Investment Research

Stocks to ConsiderSome better-ranked stocks have been discussed below:

ARKO Corp. (ARKO - Free Report) operates a chain of convenience stores in the United States. ARKO currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for ARKO's current fiscal-year sales implies a decline of 2.8%, while the same for current fiscal-year earnings implies growth of 93.3% from the year-ago reported figures. ARKO delivered a trailing four-quarter earnings surprise of 43.2%, on average.

Colruyt Group N.V. (CUYTY - Free Report) together with its subsidiaries, engages in the retail, wholesale, food service, and other activities in Belgium, France, and internationally. It presently flaunts a Zacks Rank #1.

The Zacks Consensus Estimate for CUYTY's current financial-year sales and earnings indicates 7.4% and 2.5% growth, respectively, from the last year.

Phibro Animal Health Corporation (PAHC - Free Report) operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. PAHC currently carries a Zacks Rank of 2 (Buy).

The Zacks Consensus Estimate for PAHC's current fiscal-year sales and earnings implies growth of 14.8% and 47.4%, respectively, from the year-ago actuals. PAHC delivered a trailing four-quarter earnings surprise of 16.3%, on average.

Philadelphia, Pennsylvania--(Newsfile Corp. - July 13, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Hub Group, Inc. (NASDAQ: HUBG) ("Hub Group" or the "Company") on behalf of investors who purchased or acquired Hub Group securities during the period from April 28, 2023 through May 11, 2026 (the "Class Period").

Investor Deadline: Investors who purchased or acquired Hub Group securities during the Class Period may, no later than August 28, 2026, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.

Hub Group is a transportation and logistics company based in Oak Brook, Ill., providing freight transportation and supply chain solutions across North America.

As the complaint alleges, on February 5, 2026, Hub Group announced that its financial statements for the first three quarters of 2025 should no longer be relied upon and would be restated due to an error that resulted in the understatement of purchased transportation costs and accounts payable during the first nine months of 2025. The Company estimated the total reduction related to the issue was $77 million.

Hub Group's stock price declined approximately 18%, from $51.33 per share on February 5, 2026, to $41.96 per share on February 6, 2026.

Then, on May 12, 2026, Hub Group disclosed that certain transactions had been prematurely or incorrectly recognized or not adequately supported, causing its 2023 and 2024 annual reports to be materially misstated and should no longer be relied upon. The Company also stated that it expected to conclude it had not maintained effective disclosure controls and procedures and internal control over financial reporting for 2023 and 2024.

Following this disclosure, Hub Group's stock price declined an additional 13%, from $41.86 per share on May 11, 2026, to $36.62 per share on May 12, 2026.

If you are a Hub Group investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267) 764-4865.

About Berger Montague

Berger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304888

Source: Berger Montague

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Investors with an interest in Insurance - Brokerage stocks have likely encountered both eToro Group Ltd. (ETOR) and Ryan Specialty Group (RYAN).

Key Takeaways New housing law aims to boost supply through zoning reforms and lower building costs. Homebuilders may benefit as federal incentives support new housing development. ITB and XHB offer exposure to housing stocks poised to gain from the legislation. The first major federal housing affordability legislation in nearly 30 years has officially become law, concluding months of congressional negotiations and an unusual legislative process that saw President Donald Trump decline to sign the measure, as quoted on Yahoo Finance.

Although President Trump chose not to sign the legislation, he also did not veto it. Under a constitutional provision, if the president neither signs nor vetoes a bill within 10 days while Congress remains in session, the legislation automatically becomes law. As a result, the housing bill took effect without the president's signature.

The act is designed to improve housing affordability by encouraging new home construction, expanding financing options, and reducing barriers to housing development.

Key Measures to Boost Housing SupplyThe legislation includes a broad range of initiatives aimed at increasing the nation's housing stock and lowering development costs. Key provisions include grants for local governments that ease restrictive zoning rules and promote housing construction.

Other measures include faster environmental review procedures for eligible housing projects, lower construction costs for manufactured homes, and restrictions on large institutional investors purchasing single-family homes.

Lawmakers hope these measures will help ease the nation's ongoing housing shortage and improve affordability.

Housing Industry Welcomes the LegislationThe new law has been widely welcomed across the housing sector. Note that the median U.S. home price recently reached an all-time high of $440,600. Sales of new single-family homes in the United States dropped 7.3% sequentially to a seasonally adjusted annualized rate of 580 thousand in May 2026, the lowest in four months.

New home sales declined for a second month in a row, as higher mortgage rates weighed on buyers. Meanwhile, housing supply rose to 496,000 units, equivalent to 10.3 months of supply at the last sales rate, the highest level since 2009, per Trading Economics.

Stocks & ETFs in Focus  D.R. Horton Inc. (DHI - Free Report) , Meritage Homes Corporation (MTH - Free Report) , Lennar Corporation (LEN - Free Report) and Beazer Homes USA (BZH - Free Report) should be well-positioned under the new law.

The housing industry also appears attractively valued. It trades at a forward price-to-earnings ratio of 14.75X versus 18.45X for the S&P 500. Its price-to-book ratio is equally attractive at 1.07X compared with 3.80X for the S&P 500.

Some government support was likely needed for housing companies, as the industry's earnings are projected to decline 14.66%, compared with the S&P 500's projected earnings growth of 10.05%.

The industry is also facing margin pressure, with a net margin of 6.09% compared with the S&P 500's net margin of 12.93%.

Against this backdrop, investors can consider ETFs such as the iShares U.S. Home Construction ETF (ITB - Free Report) and the SPDR S&P Homebuilders ETF (XHB - Free Report) .

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ChampionX Corporation (NASDAQ: CHX) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ChampionX securities between February 29, 2024 and April 1, 2024, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CHX.

ChampionX Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

while repurchasing millions of dollars’ worth of ChampionX Corporation (“ChampionX” or the “Company”) common stock, Defendants were in possession of material nonpublic information regarding offers made by Schlumberger Limited (“SLB”) to acquire ChampionX at a premium to prevailing market prices;Defendants failed to either abstain from trading or disclose SLB’s offer(s), which, if disclosed, would have signaled to investors that ChampionX’s stock was worth significantly more than its trading price;Defendants further failed to disclose subsequent offers and negotiations involving ChampionX and SLB; andas a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times. What's Next for ChampionX Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CHX. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in ChampionX you have until July 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to ChampionX Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for ChampionX Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Sunstone Hotel Investors (SHO) and National Health Investors (NHI). But which of these two stocks presents investors with the better value opportunity right now?

New York, New York--(Newsfile Corp. - July 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between January 28, 2025 and January 26, 2026, inclusive (the "Class Period"), of the important July 17, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Commvault securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 17, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Commvault's competitive positioning was materially weaker than defendants had represented to investors; (2) due to the undisclosed increase in competition, Commvault was forced to make significant concessions on price and contract duration for its software licenses; (3) as these concessions became unsustainable, Software as a Service ("SaaS") became a larger portion of Commvault's sales mix; (4) in turn, the increasing mix of SaaS sales, which carry shorter term durations and lower average selling prices ("ASPs"), negatively impacted Commvault's margin and Net New ARR ("NNARR"); and (5) as a result, defendants' positive statements about Commvault's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Commvault class action, go to https://rosenlegal.com/cases/commvault-systems-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304965

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

, /PRNewswire/ -- First Horizon Bank (NYSE: FHN or "First Horizon") announced today the naming of Craig A. Netterville as Senior Vice President and Baton Rouge President. Netterville has served as a leader on the Baton Rouge team for 20 years and contributed to the market's significant client growth as head of the Private Client team.

Craig A. Netterville - SVP, Baton Rouge President for First Horizon Bank "As a Baton Rouge native and graduate of LSU, Craig is the ideal leader for our team and clients," said Tony Adams, Gulf States Regional President. "He has a deep understanding of the community and our clients' needs. Under his leadership, our team will continue to deliver large bank capabilities with the high-touch, relationship-focused service and customized solutions our clients value."

Netterville has also been a lifelong leader in the community. He currently serves on the Louisiana State Civil Service Commission. He previously served as Board Chair of Franciscan Missionaries of Our Lady University, President of LA Mortgage Lenders Association, Treasurer of Istrouma Area Boy Scouts and as a Board Member of Baton Rouge Area Chamber, Knock Knock Children's Museum and Credit Bureau of Baton Rouge Foundation.  He also serves on the finance committee of OLOL Regional Medical Center.

About First Horizon Bank
First Horizon Corp. (NYSE: FHN), with $84.1 billion in assets as of March 31, 2026, is a leading regional financial services company, dedicated to helping our clients, communities and associates unlock their full potential with capital and counsel. Headquartered in Memphis, TN, the banking subsidiary First Horizon Bank operates in 12 states concentrated in the southern U.S. The Company and its subsidiaries offer commercial, private banking, consumer, small business, wealth and trust management, retail brokerage, capital markets, fixed income, and mortgage banking services. First Horizon has been recognized as one of the nation's best employers by Fortune and Forbes magazines and a Top 10 Most Reputable U.S. Bank. More information is available at www.FirstHorizon.com.

SOURCE First Horizon Bank

The Pound Sterling begins the week on a lower note, as over-the-weekend developments in the Middle East fueled inflationary pressures due to the rise in Oil prices. At the time of writing, the GBP/USD trades at 1.3369, down over 0.20%. Read More...

British Pound remains subdued as US-Iran tensions lift US DollarGBP/USD remains in negative territory after paring daily losses, trading around 1.3390 during the early European hours on Monday. The pair faces challenges as the US Dollar (USD) gains ground on rising safe-haven demand amid intensifying tensions in the Middle East. Read More...

British Pound remains depressed below 1.3400 as escalating US-Iran tensions underpin USDThe GBP/USD pair finds some support near 1.3370 after a modest gap-down opening on Monday, though it lacks bullish conviction and remains below 1.3400. Nevertheless, spot prices, for now, seem to have stalled the pullback from a nearly four-week high, around the 1.3450 area, touched on Friday amid mixed fundamental cues. Read More...

Investors interested in stocks from the Internet - Software and Services sector have probably already heard of NetEase (NTES) and Tyler Technologies (TYL). But which of these two companies is the best option for those looking for undervalued stocks?

First Hawaiian, Inc. (NASDAQ:FHB) has agreed to acquire TriCo Bancshares (NASDAQ:TCBK), a combination the bank said will create the leading Pacific banking franchise and accelerate its expansion on the US mainland.

First Hawaiian described the transaction as a strategic step that pairs two deposit-focused banking platforms, extending its reach beyond its core Hawaii market into TriCo's California footprint.

First Hawaiian, the holding company for First Hawaiian Bank, is the largest financial institution headquartered in Hawaii, with a franchise built on retail and commercial deposits across the islands.

TriCo Bancshares is the parent of Tri Counties Bank, a community-focused lender operating across Northern and Central California.

The pairing of deposit platforms sits at the core of the rationale, as low-cost deposits underpin a bank's funding and lending capacity.

Shares of First Hawaiian dropped 4.2% on Monday morning while TriCo Bancshares was up nearly 11%.

TriCo shareholders will receive 2.095 First Hawaiian shares for each TriCo share.

After a run for the ages, Bloom Energy (BE 4.88%) stock has taken a plunge. Year to date, Bloom stock has more than doubled. But a few days after announcing its landmark $25 billion agreement with Brookfield Asset Management (BAM 0.81%), the stock hit turbulence. General market volatility and a short-seller report have weighed on the stock.

The stock trades almost 30% lower from its 52-week high. For investors watching Bloom, that begs the question -- is now the buying opportunity you've been waiting for, or should you wait this one out?

Today's Change

(

-4.88

%) $

-11.95

Current Price

$

232.66

Demand for Bloom servers is booming -- can it keep up? In a nutshell, Bloom makes modular boxes that lets customers, like data centers, generate electricity on their own site instead of waiting years to connect to the grid.

These boxes, also called Bloom servers, are highly relevant right now. AI data centers need a lot of power; they need it fast, and traditional utilities are struggling to keep up. Bloom says it can deploy its servers to a customer within 90 days, and it backed this promise up last year when it delivered fully operational fuel cell systems to Oracle within 55 days.

Demand for Bloom's products has never been stronger, and its revenue growth is proof. First-quarter product revenue reached $653 million, a roughly 208% increase compared to about $212 million last year. The company has raised full-year revenue guidance to between $3.4 billion and $3.8 billion, which would represent about 68% to 88% growth from the roughly $2 billion it generated in 2025.

Image source: Bloom Energy.

To compete in the most power-hungry markets, however, Bloom will need to expand its manufacturing capacity. Last year, its annual production reached about 1 gigawatt (GW), which it claims will double to 2 gigawatts (GW) by the end of this year. That's fine progress, but it's still only a fraction of the roughly 150 GW of AI data center power demand that Bloom expects in the U.S. over the next several years.

Should you buy the dip on Bloom? Even after its recent dip, Bloom stock still sells at a pricey valuation. The company carries a $73 billion market capitalization, and the stock trades at roughly 28 times sales, which is several times higher than the average for green and renewable energy companies (about 3.75).

But when you look at Bloom's growth trajectory, it's easy to understand why investors are willing to pay a premium. The company has a $20 billion backlog and a $25 billion financing agreement with Brookfield Asset Management. Over the next two fiscal years, revenue is projected to grow fivefold.

Data by YCharts

The company still faces risks, and it needs to increase its manufacturing capacity if it wants to execute on its growth promises. Still, for those who can withstand the short-term volatility, buying the dip on Bloom could prove fruitful over the long run.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.

In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.

However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

ExlService Holdings (EXLS - Free Report) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.

Here are three of the most important factors that make the stock of this provider of outsourcing services a great growth pick right now.

Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for ExlService Holdings is 18.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 15% this year, crushing the industry average, which calls for EPS growth of 8%.

Cash Flow GrowthCash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.

Right now, year-over-year cash flow growth for ExlService Holdings is 25.5%, which is higher than many of its peers. In fact, the rate compares to the industry average of 9.3%.

While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 14.8% over the past 3-5 years versus the industry average of 8.5%.

Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

There have been upward revisions in current-year earnings estimates for ExlService Holdings. The Zacks Consensus Estimate for the current year has surged 0.1% over the past month.

Bottom LineWhile the overall earnings estimate revisions have made ExlService Holdings a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that ExlService Holdings is a potential outperformer and a solid choice for growth investors.

Monday, 13 July 2026 12:35 PM

Topic: 

Earnings STURGIS, MI / ACCESS Newswire / July 13, 2026 / Sturgis Bancorp, Inc. (OTCQX:STBI) today reported for the second quarter of 2026:

Tier 1 Capital

The Bank maintained strong capital ratios, exceeding well capitalized requirements, with Tier 1 leverage capital at 8.63%.

Key Quarterly Highlights

Net income was $2.5 million.

Earnings per share of $1.16.

Paid dividend of $0.18 per share.

Total assets increased to $1.03 billion.

From Jason J. Hyska, Sturgis Bancorp, Inc. Chief Executive Officer

"The Bank had a solid second quarter. Earnings growth and tax equivalent net interest margin are up in 2Q26 compared to 2Q25, while credit quality remains on solid footing. The Bank continues to operate cautiously in the growing uncertain economic environment. The focus of the Bank for 2026 remains relationship banking with an emphasis on expanding service offerings to existing customers across the Bank's footprint."

Quarterly Income Statement Highlights

Net income for the quarter (2Q26) was $2.5 million, an increase from both last quarter's (1Q26) $1.9 million and from the same quarter of the prior year's (2Q25) $1.6 million.

Earnings per share were $1.16 for 2Q26, $0.88 for 1Q26, and $0.76 for 2Q25.

Tax equivalent net interest margin increased to 3.77% for 2Q26 from 3.70% for 1Q26, and from 3.64% for 2Q25.

Net interest income after the provision for credit losses was $9.5 million during 2Q26, an 11.13% increase from 1Q26's $8.5 million. This was a 19.03% increase from 2Q25's $7.9 million. These fluctuations were primarily due to:

Total interest and dividend income of $12.8 million in 2Q26, compared to $12.7 million in 1Q26, and $12.3 million in 2Q25.

A reversal of the provision for credit loss of ($688,000) in 2Q26, compared to provision for credit loss expense of $121,000 in 1Q26, and $117,000 in 2Q25. The 2Q26 reversal was substantially related to a $40.1 million sale of residential mortgages.

Noninterest income totaled $2.1 million during 2Q26, a 9.59% decrease from 1Q26's $2.3 million. This was a 2.54% decrease from 2Q25's $2.2 million.

Mortgage banking activities were $242,000 in 2Q26, compared to $340,000 in 1Q26; and

Proportionate net income from unconsolidated subsidiaries was $78,000 in 2Q26, compared to $233,000 in 1Q26.

Noninterest expenses totaled $8.4 million during 2Q26, a 0.49% decrease from 1Q26's $8.5 million. This was a 4.14% increase from 2Q25's $8.1 million. The increase in 2Q26 from 1Q26 was primarily due to:

Compensation and benefits in 2Q26 were $5.0 million, compared to $4.8 million for 2Q25. Most of this difference is attributable to typical wage increases.

Year-to-Date Income Statement Highlights

Net income for the first six months of 2026 (YTD 2026) was $4.4 million compared to $3.1 million for the first six months of 2025 (YTD 2025).

Earnings per share were $2.04 for YTD 2026 and $1.43 for YTD 2025.

Tax equivalent net interest margin was 3.73% for YTD 2026 and 3.58% for YTD 2025.

Net interest income after the provision for credit losses was $18.0 million for YTD 2026, a 13.59% increase from YTD 2025's $15.8 million. This increase was primarily due to:

Total interest and dividend income of $25.5 million for YTD 2026, compared to $24.3 million for YTD 2025.

A reversal of the provision for credit loss of ($566,000) for YTD 2026, compared to a reversal of the provision for credit loss of ($41,000) for YTD 2025.

Noninterest income totaled $4.4 million for YTD 2026, a 2.37% increase from YTD 2025's $4.3 million.

Noninterest expenses totaled $16.9 million for YTD 2026, a 3.16% increase from YTD 2025's $16.4 million. This increase was primarily due to:

Compensation and benefits of $10.1 million for YTD 2026, compared to $9.7 million for YTD 2026. Most of this difference is attributable to typical wage increases.

Balance Sheet Highlights

Total assets increased to $1.03 billion at the end of 2Q26, a 1.47% increase from the end of 1Q26's $1.01 billion, and a 4.54% increase from the end of 2Q25's $985 million.

Loans, net of allowance for credit losses decreased to $755 million at the end of 2Q26, compared to $786 million at the end of 1Q26 and $778 million at the end of 2Q25. This decrease was due to the aforementioned $40.1 million sale of residential mortgages. The sale enhanced the Bank's interest rate risk profile.

Total deposits decreased to $893 million at the end of 2Q26, compared to $908 million at the end of 1Q26, while deposits increased compared to $882 million at the end of 2Q25.

Subordinated debentures were paid in full as of the end of 4Q25, while having a balance of $15.0 million at the end of 2Q25.

Total equity at the end of 2Q26 was $66.8 million, compared to $64.7 million at the end of 1Q26, and $58.5 million at the end of 2Q25.

Book value per share was $30.73 ($26.41 tangible) at the end of 2Q26, compared to $29.78 ($25.68 tangible) at the end of 1Q26, and $27.06 ($22.93 tangible) at the end of 2Q25.

About Sturgis Bancorp, Inc.

Sturgis Bancorp, Inc. is the holding company for Sturgis Bank & Trust Company (the Bank), and its subsidiaries: Oakleaf Financial Services, Ayres/Oak Insurance, and Oak Title Services. The Bank provides a full array of trust, commercial, and consumer banking services from banking centers in: Sturgis, Bangor, Bronson, Centreville, Climax, Colon, Marshall, Niles, Portage, South Haven, St. Joseph, Three Rivers, and White Pigeon, Michigan. Oakleaf Financial Services offers a complete range of investment and financial-advisory services. Ayres/Oak Insurance offers various competitive commercial and consumer insurance products. Oak Title Services offers commercial and consumer title insurance services.

Forward-Looking Statements

This release contains statements that constitute forward-looking statements. These statements appear in several places in this release and include statements regarding intent, belief, outlook, objectives, efforts, estimates, or expectations of Sturgis Bancorp, Inc. (Bancorp), primarily with respect to future events and the future financial performance of Bancorp. Any such forward-looking statements are not guarantees of future events or performance and involve risks and uncertainties, and actual results may differ materially from those in the forward-looking statements. Factors that could cause a difference between an ultimate actual outcome and a preceding forward-looking statement include, but are not limited to, changes in interest rates and interest rate relationships; demand for products and services; the degree of competition by traditional and non-traditional competitors; changes in banking laws and regulations; changes in tax laws; changes in prices, levies, and assessments; the impact of technological advances; government and regulatory policy changes; the outcome of any pending or future litigation and contingencies; trends in consumer behavior and ability to repay loans; and changes in the world, national, and local economies. Bancorp undertakes no obligation to update, amend, or clarify forward-looking statements as a result of new information, future events, or otherwise. The numbers presented herein are unaudited.

For additional information, visit our website at www.sturgis.bank.

Sturgis Bancorp, Inc. Contacts

Jason J. Hyska, CEO & President, or Brian P. Hoggatt, CFO - (269) 651-9345

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited - Amounts in thousands, except share and per share data)

Three Months Ended

Jun 30,

Mar 31,

Jun 30,

2026

2026

2025

2Q26

1Q26

2Q25

Interest and dividend income

Loans, including fees

$

11,356

$

11,220

$

11,221

Taxable securities

1,200

1,273

811

Tax-exempt securities

39

38

38

Dividend income on securities

203

208

210

Total interest and dividend income

12,798

12,739

12,280

Interest expense

Deposits

3,543

3,698

3,707

Borrowed funds

490

413

514

Total interest expense

4,033

4,111

4,221

Net interest income

8,765

8,628

8,059

Credit loss expense (reversal)

(688

)

121

117

Net interest income, after credit loss expense (reversal)

9,453

8,507

7,942

Noninterest income

Service charges on deposits and other fees

338

358

334

Interchange income

405

332

364

Investment brokerage commission income

814

787

702

Mortgage banking activities

242

340

311

Trust fee income

50

69

135

Earnings on cash value of bank-owned life insurance

117

115

107

Proportionate net income from unconsolidated subsidiaries

78

233

41

Other income

64

98

169

Total noninterest income

2,108

2,332

2,163

Noninterest expenses

Compensation and benefits

4,991

5,083

4,758

Occupancy and equipment

1,187

1,240

1,137

Interchange expenses

201

202

198

Data processing

184

172

378

Professional services

165

176

133

Advertising

285

240

255

FDIC premiums

193

178

159

Other expenses

1,213

1,170

1,067

Total noninterest expenses

8,419

8,461

8,085

Income before income taxes

3,142

2,378

2,020

Income tax expense

621

466

378

Net income

$

2,521

$

1,912

$

1,642

Earnings (loss) per share

$

1.16

$

0.88

$

0.76

Dividends per share

$

0.18

$

0.18

$

0.17

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited - Amounts in thousands, except share and per share data)

Six Months Ended

Jun 30,

Jun 30,

2026

2025

2Q26

2Q25

Interest and dividend income

Loans, including fees

$

22,576

$

22,151

Taxable securities

2,473

1,637

Tax-exempt securities

77

77

Dividend income on securities

411

423

Total interest and dividend income

25,537

24,288

Interest expense

Deposits

7,241

7,367

Borrowed funds

902

1,151

Total interest expense

8,143

8,518

Net interest income

17,394

15,770

Credit loss expense (reversal)

(566

)

(41

)

Net interest income, after credit loss expense (reversal)

17,960

15,811

Noninterest income

Service charges on deposits and other fees

696

653

Interchange income

737

680

Investment brokerage commission income

1,601

1,400

Mortgage banking activities

583

761

Trust fee income

119

234

Earnings on cash value of bank-owned life insurance

232

212

Gain on sale of real estate owned, net

-

1

Proportionate net income from unconsolidated subsidiaries

312

212

Other income

161

185

Total noninterest income

4,441

4,338

Noninterest expenses

Compensation and benefits

10,074

9,741

Occupancy and equipment

2,427

2,268

Interchange expenses

403

380

Data processing

356

727

Professional services

341

322

Advertising

526

473

FDIC premiums

371

335

Other expenses

2,383

2,118

Total noninterest expenses

16,881

16,364

Income before income taxes

5,520

3,785

Income tax expense

1,087

697

Net income (loss)

$

4,433

$

3,088

Earnings (loss) per share

$

2.04

$

1.43

Dividends per share

$

0.36

$

0.34

CONSOLIDATED BALANCE SHEETS

(Unaudited - Amounts in thousands, except share and per share data)

Jun 30,

Mar 31,

Jun 30,

2026

2026

2025

2Q26

1Q26

2Q25

ASSETS

Cash and cash equivalents

Cash and due from financial institutions

$

11,292

$

11,908

$

12,688

Other short-term investments

53,856

41,677

26,295

Total cash and cash equivalents

65,148

53,585

38,983

Debt securities available-for-sale

112,577

84,910

76,546

Debt securities held-to-maturity

17,832

18,058

18,748

Federal Home Loan Bank stock

9,786

9,786

9,786

Loans held for sale

5,256

3,806

3,725

Loans, net of allowance for credit losses of $8,435; $9,075;

and $9,254 at 2Q26; 1Q26; and 2Q25, respectively

755,118

785,920

777,728

Mortgage servicing rights

3,567

3,084

3,103

Real estate owned, net

4,068

821

335

Premises and equipment, net

18,222

18,488

19,629

Goodwill

5,834

5,834

5,834

Bank-owned life insurance

16,071

15,953

15,614

Accrued interest receivable

3,604

3,709

3,690

Other assets

12,676

10,917

11,282

Total assets

$

1,029,759

$

1,014,871

$

985,003

LIABILITIES AND STOCKHOLDERS' EQUITY

Liabilities

Deposits

Noninterest-bearing

$

175,449

$

164,883

$

164,532

Interest-bearing

717,465

743,498

717,923

Total deposits

892,914

908,381

882,455

Federal Home Loan Bank advances and other borrowings

56,620

30,687

15,680

Subordinated debentures

-

-

14,959

Accrued interest payable

2,165

1,776

2,039

Other liabilities

11,256

9,363

11,325

Total liabilities

962,955

950,207

926,458

Stockholders' equity

Common stock - $1 par value: authorized - 9,000,000 shares;

issued and outstanding - 2,173,791 shares at 2Q26;

2,171,041 shares at 1Q26; and 2,163,691 shares at 2Q25

2,174

2,171

2,164

Additional paid-in capital

8,993

8,926

8,776

Retained earnings

63,037

60,907

55,751

Accumulated other comprehensive (loss)

(7,400

)

(7,340

)

(8,146

)

Total stockholders' equity

66,804

64,664

58,545

Total liabilities and stockholders' equity

$

1,029,759

$

1,014,871

$

985,003

SOURCE: Sturgis Bancorp, Inc.

13.7.2026 19:44

Americké akciové trhy dnes oslabují, když nová eskalace mezi USA a Íránem v Perském zálivu znovu vytlačila výše ceny ropy a zvýšila nervozitu investorů. Prezident Donald Trump uvedl, že Spojené státy obnovují blokádu íránské lodní dopravy v Zálivu a zároveň chtějí udržet Hormuzský průliv otevřený poté, co si obě strany o víkendu vyměnily další raketové a dronové útoky. Vývoj podkopává předběžnou dohodu z minulého měsíce, která měla po 60 dnech jednání vést k otevření průlivu a ukončení války. Trh zároveň čeká na důležitý týden makrodat a kvartálních výsledků: v úterý bude zveřejněna americká spotřebitelská inflace, šéf Fedu Kevin Warsh vystoupí před Kongresem a velké banky jako již tradičně zahájí výsledkovou sezonu za druhý kvartál. Očekává se, že zisky firem z indexu S&P 500 meziročně vzrostly o 23,7 %, zatímco trh dle průzkumů mezi analytiky stále zaceňuje alespoň jedno zvýšení sazeb Fedu o 25 bazických bodů do konce roku.

Sektorově je největší tlak patrný v technologiích a polovodičích, kde pokračuje vybírání zisků po předchozí silné AI rally. Informační technologie v rámci S&P 500 ztrácejí 1,8 % a jsou nejslabším sektorem dne, vedle toho sledovaný Philadelphia Semiconductor Index klesá o 3,7 % a nachází se už více než 14 % pod rekordem z konce června. Z jedenácti hlavních sektorů S&P 500 najdeme pět v záporu. Ropa po zprávách o nové eskalaci prudce zdražila. WTI rostle o 4,47 % na 74,60 USD za barel a Brent o 4,41 % na 79,36 USD. Výnosy amerických dluhopisů rostly kvůli obavám z inflačních tlaků a desetiletý výnos se zvýšil na 4,598 %, třicetiletý na 5,093 % a dvouletý na 4,248 %, tedy nejvýše od února 2025. Euro oslabilo na 1,14 USD.

Z jednotlivých akcií jsou pod největším tlakem paměťové polovodiče, které letos výrazně těžily z optimismu kolem AI, ale nyní čelí vybírání zisků. Sandisk propadá o 13 %, Western Digital o více než 6 % a Micron Technology (MU) odepisuje 5 %. Čerstvě v USA listované korejské akcie SK Hynix ztrácí přes 9 %. Pokles polovodičů měl širší dopad i mimo USA: jihokorejský KOSPI se propadl téměř o 9 %, protože se z něj stal citlivý barometr nálady vůči čipovému sektoru.

Index S&P 500 -0,6 % na 7530 b.
Index Dow Jones -0,35 % na 52453 b.
Index Nasdaq Composite -1,33 % na 25957 b.

Nejsilnější sektory S&P Změna Nejslabší sektory S&P Změna Energie +2,7 % Informační technologie -1,8 % Utility +0,5 % Průmysl -1,1 % Zbytná spotřeba +0,4 % Základní materiály -0,9 % Nejsilnější akcie S&P Změna Nejslabší akcie S&P Změna Intuit (INTU) +7 % APPLVN CRP A O (APP) -13 % WORKDAY I (WDAY) +5,8 % SANDISK CORP O (SNDK) -13 % Salesforce (CRM) +5,6 % MRVL TCHNLGY O (MRVL) -7,3 % Gartner (IT) +5,3 % Western Digital (WDC) -6,9 % FactSet Research Systems (FDS) +5 % Seagate Technology Holdings ( STX) -6,3 % Zdroj: Reuters

Martin Varecha
Fio banka, a.s.
Prohlášení

Vistra trades below industry and historical valuations, but power-price volatility, high debt and project risks suggest investors should await a better entry.

Key Takeaways PNC's Q2'26 earnings are projected to be $4.51 per share, up 17.1% year over year.Quarterly revenues are estimated to be $6.42 billion, reflecting 12.8% year-over-year growth.A stable interest rate environment, loan growth and FirstBank integration are likely to aid quarterly results. The PNC Financial Services Group, Inc. (PNC - Free Report) is scheduled to report second-quarter 2026 results on July 15, before market open. The company’s revenues and earnings are expected to have improved on a year-over-year basis.

In the first quarter of 2026, the company’s earnings surpassed the Zacks Consensus Estimate, driven by higher net interest income (NII) and fee income. Further, rising loan and deposit balances supported the results. However, higher expenses acted as a headwind.

PNC has an impressive earnings surprise history. Its earnings surpassed estimates in the trailing four quarters with an average surprise of 8.95%.

Factors to Impact PNC Financial’s Q2 EarningsNII & Loans: In the second quarter of 2026, the Federal Reserve kept interest rates unchanged while noting that economic activity continued to expand at a solid pace despite elevated uncertainty and inflation remaining above its 2% target. The stable rate environment is likely to have supported PNC Financial's NII growth.

Management expects NII to rise approximately 3% sequentially in the second quarter of 2026.

The Zacks Consensus Estimate for NII of $4.1 billion indicates a sequential rise of nearly 3.2%.

Per the Fed’s latest data, demand for commercial and industrial, real estate and consumer loans was decent in the second quarter of 2026. As such, a stable rate environment and decent loan demand are expected to have supported the company's overall lending activity in the quarter to be reported.

The Zacks Consensus Estimate for average interest-earning assets is pegged at $552.4 billion, indicating a sequential rise of 2.2%. The company expects average loans to rise nearly 2%-3% sequentially in the second quarter of 2026.

Non-Interest Revenues: The second quarter remained challenging for the mortgage business, with mortgage rates hovering around the mid-6.5% range and affordability remaining strained. While purchase activity continued to face pressure from inventory constraints, refinancing activity witnessed a modest improvement. As a result, PNC's residential and commercial mortgage revenues are likely to have improved in the quarter to be reported.

The Zacks Consensus Estimate for residential and commercial mortgage revenues is pegged at $131.1 million, indicating a sequential rise of 11.1%.

The second quarter witnessed solid client activity and market volatility, though both were less pronounced than in the previous quarter. Market conditions were shaped by shifting expectations around artificial intelligence, persistent geopolitical tensions, lingering inflation concerns and the Fed's relatively hawkish monetary policy stance. Volatility across equity markets, commodities, bonds and foreign exchange is likely to have supported client activity. As a result, PNC Financial's asset management and brokerage income is likely to have improved in the quarter to be reported.

The Zacks Consensus Estimate for the metric is pegged at $430.7 million, indicating a nearly 2.5% rise sequentially.

Global mergers and acquisitions (M&A) activity moderated in the second quarter of 2026 after a strong start to the year, as ongoing geopolitical uncertainty, elevated inflation, a persistent backlog of private equity exits and higher interest rates weighed on deal-making. While deal value declined as only a few large transactions dominated the market, M&A volumes improved year over year. Despite the challenging backdrop, the increase in deal volumes is likely to have supported PNC's capital markets and advisory revenues in the quarter to be reported.

The Zacks Consensus Estimate for the company's capital markets and advisory income is pinned at $478.3 million, indicating a sequential increase of nearly 3.3%.

Further, the Zacks Consensus Estimate for card and cash management revenues is pinned at $765.9 million, indicating a sequential increase of 3.7%. The consensus estimate for lending and deposit services is pegged at $338.5 million, indicating a marginal decline from the previous quarter's actual.

Management expects fee income to decline nearly 2.5% sequentially in the second quarter of 2026.

The Zacks Consensus Estimate for non-interest income is pegged at $2.33 billion, indicating a 5.6% increase from the previous quarter.

Expenses: The company's expenses are expected to have remained elevated in the second quarter of 2026, mainly due to FirstBank integration costs. Continued investments in franchise expansion, technology and digitalization are also likely to have kept expenses high.

Management expects non-interest expenses to rise nearly 2% sequentially in the second quarter of 2026.

Asset Quality: PNC Financial is likely to have maintained elevated reserves, particularly in its commercial lending portfolio, amid persistent inflation and geopolitical uncertainty stemming from the Middle East conflict. Additionally, the Fed's June statement signaling the possibility of a rate hike is expected to have prompted the company to remain cautious and build substantial provisions for potential credit losses in the second quarter of 2026.

Management expects net charge-offs to be around $225 million, down from $253 million in the first quarter of 2026.

The Zacks Consensus Estimate for non-performing assets is pegged at $2.55 billion, indicating an increase of 7% from the previous quarter. Also, the consensus estimate for non-performing loans is pinned at $2.45 billion, implying a sequential rise of 9.3%.

What Our Model Unveils for PNCOur proven model does not conclusively predict an earnings beat for PNC Financial this time. The combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. This is not the case here.

You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP: PNC Financial has an Earnings ESP of -0.30%.

Zacks Rank: The company currently carries a Zacks Rank of 3.

PNC Financial’s Q2 Earnings & Sales ExpectationsThe Zacks Consensus Estimate for second-quarter earnings per share has been revised downward to $4.51 over the past seven days. This implies a year-over-year rise of 17.1%.

The Zacks Consensus Estimate for quarterly revenues of $6.42 billion indicates a 12.8% year-over-year increase. PNC projects total revenues to rise approximately 3.5% in the second quarter of 2026 from the $6.2 billion reported in the first quarter of 2026.

Stocks to ConsiderHere are a couple of bank stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time:

The Earnings ESP for M&T Bank (MTB - Free Report) is +0.13% and carries a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The company is slated to report second-quarter 2026 results on July 15, 2026. Over the past seven days, the Zacks Consensus Estimate for MTB's quarterly earnings has remained unchanged at $4.66 per share.

U.S. Bancorp (USB - Free Report) is also scheduled to announce second-quarter 2026 results on July 16, 2026. The company has an Earnings ESP of +0.34% and a Zacks Rank #2 at present.

Quarterly earnings estimates for USB have been revised upward to $1.28 per share over the past week.

Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Virtu Financial (VIRT) and Brookfield Asset Management (BAM). But which of these two stocks offers value investors a better bang for their buck right now?

@ProsperTradingAcademy's Scott Bauer walks us through today's tech-centric Big 3. He highlights the AI memory trade through Western Digital (WDC) and the Roundhill Memory ETF (DRAM), along with Valero Energy (VLO) and the slow but steady rise the company has seen.

Investors in Sylvamo Corporation (SLVM - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $70.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?Clearly, options traders are pricing in a big move for Sylvamo shares, but what is the fundamental picture for the company? Currently, Sylvamo is a Zacks Rank #3 (Hold) in the Paper and Related Products industry that ranks in the Bottom 10% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from $1.64 per share to $1.56 in that period.

Given the way analysts feel about Sylvamo right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.